advertisement

Topcon

Abstract #78256 Published in IGR 19-4

Old and New Drug Classes Expanding To Include Glaucoma Treatments

Kish T
P and T 2018; 43: 489-502


Poor patient adherence is fueling keen interest in the development of drugs for glaucoma management. Several long-acting formulations of existing medications are in the early stages of development, as are new therapeutic classes such as guanylate cyclase activators.


Classification:

11.16 Vehicles, delivery systems, pharmacokinetics, formulation (Part of: 11 Medical treatment)
11.14 Investigational drugs; pharmacological experiments (Part of: 11 Medical treatment)



Issue 19-4

Change Issue


advertisement

Oculus